Kemp Proteins (formerly Kempbio) is a leading provider of gene-to-protein bioservices. For more than 20 years, Kemp’s team of protein problem-solvers has delivered best-in-class services that optimize productivity and mitigate risk for life sciences innovators developing protein-based products, including human and veterinary biopharmaceuticals, vaccines, and diagnostics. Kemp Proteins is a Six.02 Bioservices member company.
Location: United States, Maryland, Frederick
Employees: 11-50
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 6
| Date | Title | Description |
| 23.01.2024 | ZoBio Sells to Oncodesign Services | BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services.. The full press release is below. Dijon, France & Leiden,... |
| 17.10.2022 | FDA Awards Kemp Proteins Contract to Develop Monoclonal Antibodies for SARS-CoV-2 and Influenza Vaccine Potency Assays | FREDERICK, Md. (PRWEB) October 17, 2022 Kemp Proteins announced today that it had been selected by the United States Food and Drug Administration (FDA) to develop monoclonal antibodies to SARS-CoV-2 and Influenza molecules. The FDA’s Labora... |
| 22.06.2022 | Kemp Proteins Secures $5M Growth Financing from BroadOak Capital Partners | "Broadoak’s growth investment will enable us to acquire several S.I.P. fermenters, digitized controllers with off-site monitoring capabilities and additional lab space." - Michael Keefe, CEO Kemp Proteins FREDERICK, Md. (PRWEB) Ju... |
| 12.04.2022 | Kemp Proteins’ Quality Management System receives ISO13485:2016 Certification | “Achieving these ISO certifications affirms that we have successfully implemented a QMS that conforms to the ISO world-wide standards and represents important milestones for our company.” - David Hicks, COO and Head of Quality, Kemp Protein... |
| 02.02.2021 | Kemp Proteins Elevates Carter Mitchell to Chief Scientific Officer | “Since joining us in June 2020, Carter has had a major impact on our use of technology and new methodology for protein purification.” said David Hicks, COO, Kemp Proteins FREDERICK, Md. (PRWEB) February 02, 2021 Kemp Proteins, a leading pro... |
| 08.12.2020 | Kemp Proteins Enter Strategic Partnership for Commercialization of ArtiaBio Technology Platform for Stable Cell Line Development | “The addition of a proprietary technology for Stable Cell Line Development represents an important milestone and reflects our commitment to growing our company with high-quality bioservices technologies.” - Michael Keefe, CEO, Kemp Proteins... |